Search Results - "BEDI, Atul"
-
1
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy
Published in Nature communications (21-02-2018)“…A majority of cancers fail to respond to immunotherapy with antibodies targeting immune checkpoints, such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) or…”
Get full text
Journal Article -
2
Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA
Published in Nature communications (16-09-2015)“…Lungs resected for adenocarcinomas often harbour minute discrete foci of cytologically atypical pneumocyte proliferations designated as atypical adenomatous…”
Get full text
Journal Article -
3
SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
Published in Clinical cancer research (01-09-2017)“…We previously demonstrated an association between decreased expression and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC). The purpose…”
Get full text
Journal Article -
4
The relative expression of Mig6 and EGFR is associated with resistance to EGFR kinase inhibitors
Published in PloS one (31-07-2013)“…The sensitivity of only a few tumors to anti-epidermal growth factor receptor EGFR tyrosine kinase inhibitors (TKIs) can be explained by the presence of EGFR…”
Get full text
Journal Article -
5
Conversion of Bcl-2 to a bax-like death effector by caspases
Published in Science (American Association for the Advancement of Science) (12-12-1997)“…Caspases are a family of cysteine proteases implicated in the biochemical and morphological changes that occur during apoptosis (programmed cell death). The…”
Get full text
Journal Article -
6
Adenylate kinase 3 sensitizes cells to cigarette smoke condensate vapor induced cisplatin resistance
Published in PloS one (15-06-2011)“…The major established etiologic risk factor for bladder cancer is cigarette smoking and one of the major antineoplastic agents used for the treatment of…”
Get full text
Journal Article -
7
Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL
Published in Cancer research (Chicago, Ill.) (15-12-2004)“…The majority of colorectal cancers have lost/inactivated the p53 tumor suppressor gene. Using isogenic human colon cancer cells that differ only in their p53…”
Get full text
Journal Article -
8
Inhibition of apoptosis during development of colorectal cancer
Published in Cancer research (Chicago, Ill.) (01-05-1995)“…Colorectal tumorigenesis proceeds through an accumulation of specific genetic alterations. Studies of the mechanism by which these genetic changes effect…”
Get full text
Journal Article -
9
BCR-ABL-Mediated Inhibition of Apoptosis With Delay of G2/M Transition After DNA Damage: A Mechanism of Resistance to Multiple Anticancer Agents
Published in Blood (01-08-1995)“…A critical determinant of the efficacy of antineoplastic therapy is the response of malignant cells to DNA damage induced by anticancer agents. The p53…”
Get full text
Journal Article -
10
The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis
Published in Gastroenterology (New York, N.Y. 1943) (01-09-1995)“…The mechanism by which sulindac causes regression of adenomas in patients with familial adenomatous polyposis (FAP) is unclear. Conflicting data on the drug's…”
Get more information
Journal Article -
11
Potential methods to circumvent blocks in apoptosis in lymphomas
Published in Current opinion in oncology (01-09-2002)“…We review our current understanding of the molecular determinants and mechanisms of lymphocyte apoptosis and identify the key regulators of these…”
Get full text
Journal Article -
12
Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: Synergism with sulindac-mediated inhibition of Bcl-xL
Published in Cancer research (Chicago, Ill.) (15-03-2002)Get full text
Journal Article -
13
The TGFβ―miR200―MIG6 Pathway Orchestrates the EMT-Associated Kinase Switch That Induces Resistance to EGFR Inhibitors
Published in Cancer research (Chicago, Ill.) (15-07-2014)“…Although specific mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) identify tumors that are responsive to EGFR tyrosine…”
Get full text
Journal Article -
14
BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia
Published in Blood (01-06-1993)“…Chronic myeloid leukemia (CML) is characterized by an initial chronic phase of expanded yet orderly clonal hematopoiesis that is distinguished by the BCR-ABL…”
Get full text
Journal Article -
15
Immune profiles in primary squamous cell carcinoma of the head and neck
Published in Oral oncology (01-09-2019)“…•TCIP-L SCCHN enriched for β-catenin, Hedgehog pathways, NSD1 mutations, EGFR amplifications.•TCIL-H SCCHN enriched for MAPK/ERK, JAK/STAT pathways, CASP8…”
Get full text
Journal Article -
16
Inhibition of TGF-β enhances the in vivo antitumor efficacy of EGF receptor-targeted therapy
Published in Molecular cancer therapeutics (01-11-2012)“…EGF receptor (EGFR)-targeted monoclonal antibodies (mAb), such as cetuximab, execute their antitumor effect in vivo via blockade of receptor-ligand…”
Get full text
Journal Article -
17
Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis
Published in Cancer research (Chicago, Ill.) (01-02-1995)“…Chronic myeloid leukemia is a disease marked by expanded clonal hematopoiesis; it is incurable by chemotherapy or radiation but is cured in a majority of…”
Get full text
Journal Article -
18
NF-κB in cancer—a friend turned foe
Published in Drug resistance updates (01-02-2004)“…The nuclear factor of κB (NF-κB) family of heterodimeric transcription factors plays an instrumental role in immune, inflammatory, and stress responses. NF-κB…”
Get full text
Journal Article -
19
A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma
Published in Oral oncology (01-04-2015)“…Summary Introduction A combination of cetuximab and sorafenib in patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)…”
Get full text
Journal Article -
20
Regulation of p53 Family Member Isoform ΔNp63α by the Nuclear Factor-κB Targeting Kinase IκB Kinase β
Published in Cancer research (Chicago, Ill.) (15-02-2010)“…The p53 family gene p63 plays an instrumental role in cellular stress responses including responses to DNA damage. In addition to encoding a full-length…”
Get full text
Journal Article